Savonix gets $5.1M to advance digital neurocognitive assessment (MobiHealth News):
“San Francisco-based Savonix, maker of an app for neurocognitive assessment, has raised $5.1 million in a new round of funding. DigiTx Partners led the round with additional contribution from ReThink Impact.
The company, which was founded in 2015, is made up of neuroscientists and gaming experts. Its product, Savonix Mobile, is a 30-minute brain training and testing app based on existing clinical guidelines and procedures. It’s designed to replace a costly, often time-consuming process that involves a clinician working with pen and paper to screen patients. The app is available internationally via healthcare licenses and third party partnerships…Specifically, Savonix will use the new funding to expand into new international markets including China and Japan.
In addition to the funding, Savonix announced some new strategic partnerships. The company will work with New York University (NYU), CereScan, Proove Biosciences, Alkahest and Senescence Life Sciences to establish a new gold standard for cognitive assessment.”
News in Context:
- Five reasons the future of brain enhancement is digital, pervasive and (hopefully) bright
- 10 neurotechnologies about to transform brain enhancement and brain health
- 2017 SharpBrains Virtual Summit: Brain Enhancement in the Digital Age (December 5–7th, 2017)
- Infographic on the Digital Brain Health Market 2012–2020